Status
Conditions
Treatments
About
The study will be offered to patients with non-small cell lung carcinoma diagnosed at stage IV and receiving first-line treatment.
The patient will benefit from a complete assessment at inclusion (clinical exam, imagery, biological exam, dietary consultation, test LFQP.
At the end of this 1st evaluation, patients in whom the diagnosis of undernutrition is made will benefit from dietary management with personalized advice that will take into account the symptoms of cancer, the possible side effects of treatments as well as the social environment.
Every two cures, i.e. every 4 to 6 weeks, these examens will be performed until the occurrence of an event (progression of the disease according to the RECIST criteria, death or change of therapeutic line). At the end of these assessments, patients will benefit from dietary management with a readjustment of personalized advice that will take into account the difficulties highlighted during the assessment.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
190 participants in 1 patient group
Loading...
Central trial contact
Sophie rs BETTING; Marjolaine rs GEORGES, Pr
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal